105 related articles for article (PubMed ID: 9421211)
1. Synergism of dimethoxybenzosemiquinone free radicals and CD4+ T-lymphocytes to suppress Ehrlich ascites tumor.
Morgan CD; Lefkowitz SS; Everse J
Proc Soc Exp Biol Med; 1998 Jan; 217(1):89-96. PubMed ID: 9421211
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-controlled scavenging of ascorbyl and 2,6-dimethoxy-semiquinone free radicals in Ehrlich ascites tumor cells.
Pethig R; Gascoyne PR; McLaughlin JA; Szent-Györgyi A
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1439-42. PubMed ID: 3856273
[TBL] [Abstract][Full Text] [Related]
3. Probable immune system mediation of the antitumor activity of the 2,6-dimethoxybenzo-p-semiquinone radical.
Morgan CD; Combs SH; Everse J
Proc Soc Exp Biol Med; 1995 Mar; 208(3):294-9. PubMed ID: 7878069
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology.
Newell CK; Martin S; Sendele D; Mercadal CM; Rouse BT
J Virol; 1989 Feb; 63(2):769-75. PubMed ID: 2536102
[TBL] [Abstract][Full Text] [Related]
5. Electron spin resonance studies of the interaction of oxidoreductases with 2,6-dimethoxy-p-quinone and semiquinone.
Gascoyne PR; Pethig R; Szent-Györgyi A
Biochim Biophys Acta; 1987 Feb; 923(2):257-62. PubMed ID: 3028490
[TBL] [Abstract][Full Text] [Related]
6. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the 2,6-dimethoxysemiquinone and ascorbyl free radicals with Ehrlich ascites cells: a probe of cell-surface charge.
Pethig R; Gascoyne PR; McLaughlin JA; Szent-Györgyi A
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2088-91. PubMed ID: 6585788
[TBL] [Abstract][Full Text] [Related]
8. Ascorbate-quinone interactions: electrochemical, free radical, and cytotoxic properties.
Pethig R; Gascoyne PR; McLaughlin JA; Szent-Györgyi A
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):129-32. PubMed ID: 6296861
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
10. Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies.
Naessens J; Scheerlinck JP; De Buysscher EV; Kennedy D; Sileghem M
Vet Immunol Immunopathol; 1998 Jul; 64(3):219-34. PubMed ID: 9730218
[TBL] [Abstract][Full Text] [Related]
11. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
12. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
Staats HF; Oakes JE; Lausch RN
J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
Lucas B; Engel A; Camus D; Haque A
Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody.
Ayliffe W; Alam Y; Bell EB; McLeod D; Hutchinson IV
Br J Ophthalmol; 1992 Oct; 76(10):602-6. PubMed ID: 1358194
[TBL] [Abstract][Full Text] [Related]
15. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
16. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection.
Kasaian MT; Leite-Morris KA; Biron CA
J Immunol; 1991 Mar; 146(6):1955-63. PubMed ID: 1672337
[TBL] [Abstract][Full Text] [Related]
17. Induction of long-term H-Y-specific tolerance in female mice given male lymphoid cells while transiently depleted of CD4+ or CD8+ T cells.
VanderVegt FP; Johnson LL
J Exp Med; 1993 Jun; 177(6):1587-92. PubMed ID: 8098730
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
[TBL] [Abstract][Full Text] [Related]
19. Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice.
Rice JC; Bucy RP
J Immunol; 1995 Jun; 154(12):6644-54. PubMed ID: 7539027
[TBL] [Abstract][Full Text] [Related]
20. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
